write an interview of covid 19 warrior who is also a doctor
Answers
Answer:
Coronavirus pandemic is not just about the virus itself. It has brought with it hunger, loneliness, homelessness, violence and domestic abuse. At such a time, there are people around the country rising to lead community work, bring support and service the people selflessly in different ways they can. These bravehearts, are our true Corona Warriors. We have got you a list of 27 such people and teams at work. If you have such a story to share, do write to us at [email protected].
Mahita Nagaraj
Mahita Nagaraj started Caremongers India, under which volunteers provide medicines and grocery to senior citizens, needy and physically challenged people. “Everyone’s sitting at home, if there’s something you can to ease somebody’s else life, then why not?” she told SheThePeople in an interview. Mahita’s story is inspirational, and she has now started living away from her family to ensure she doesn’t carry any infection to them while doing this community work. You can also read a detailed interview with her.
Minal Dakhave Bhonsle
Minal Dakhave Bhonsle, who created India’s first coronavirus testing kit, is a virologist who will now go down in history as the woman who gave India its first coronavirus testing kit. She is the research and development chief at Pune-based Mylab Discovery Solutions. Bhonsle also has experience of working on the swine flu at NIV, Pune. Read more about her ground breaking work here.
Captain Swati Rawal
Captain Swati Rawal was the commander of Air India 777 which flew to Rome to rescue the Indians stranded in the Italian capital. The mission withdrew 263 Indians from Italy. Impressed? And mind numbing. She is indeed cool. More on her, on this link.
Dr Shifa Mohammed
Dr Shifa Mohammed from Kerala decided to postpone her wedding and chose to treat her COVID-19 afflicted patients struggling for life. “Marriage can wait, but not my patients”, she said. Read how she prioritised her duty over personal life
Titiksha Kashyap
Titiksha Kashyap, a 22-year-old student of the IIMC Delhi, is working with NGOs who are actively serving the daily wagers and other people in need. The NGOs provide food to the stray dogs, old-age homes and the daily wage earners. She lives in a society in Noida where the inhabitants are collecting and distributing food to the daily wage earners nearby as well.
Kirti Mittal
Kirti Mittal, 21-year-old BA law student living in Ganganagar, Rajasthan, is setting an example by joining her family in distributing food packages to people in need. Her family has also given paid leave to their house helps and the labourers working in their factory.
Anita Harini
Anita Hirani has been inspiring the masses by volunteering and providing free meals for the elderlies and the vulnerable in Mumbai. She has been cooking food at her own house and supplying them to the needy elderlies amidst the coronavirus crisis.
Answer:
I’ve noted confusion about what testing means. There is more to testing than just collecting the specimen. The actual testing for this virus, and for many other infectious diseases, is done in clinical laboratories. SARS-CoV-2 is an RNA virus, so most often, highly sensitive molecular tests are used to pick up the specific RNA of this virus and not other coronaviruses.
Before the outbreak, we had no tests for this virus. Initially, clinical microbiology and public health laboratories had to develop their own tests. Today, we also have tests made by companies and sold to laboratories to perform. Testing is more broadly available than it was back in March, but we continue to have supply chain shortages. Many laboratories have multiple tests in place just to make sure that at least 1 of them has enough supplies to be run at any given time.
To test for viral RNA, there is typically a first step, where RNA of the virus is extracted from the patient specimen; a second step, where that RNA is converted to DNA; and a third step, where the DNA is amplified with primers that are specific to SARS-CoV-2. There can be subtle variations to this.
This is not a trivial type of testing. Testing should be performed by trained laboratorians to make sure it’s done correctly. Because these tests are, by design, quite sensitive, if quality processes are not in place where testing is performed, results can be falsely positive. In addition, some tests are more sensitive than others. And we’ve learned that not every infected person will test positive for viral RNA with a single test. Results can depend on the way the specimen is collected, the type of specimen collected, the timing of specimen collection relative to timing of acquisition of the virus, the person’s immune system and the specific test being performed, among other factors.
Who should get an antibody test? What are the benefits of getting one?
Antibody tests are markers of past infection with COVID-19. For example, if in the past you came in contact with someone who tested positive for COVID-19, and then you experienced symptoms, such as cough, fever, difficulty breathing etc., that could have been caused by COVID-19, but have now recovered and were never tested, antibody testing could provide an indication that you were indeed infected. In this way, antibody testing is useful for epidemiologic studies to determine what percentage of a population has been previously infected. Antibody testing can also facilitate contact tracing and help identify potential convalescent plasma donors. At the current time, the American Society for Microbiology is working with the Infectious Diseases Society of America to develop guidelines around the use of serologic testing for COVID-19. A big challenge is that we don’t know if infection confers protective immunity — that is, whether once you’ve been infected, you can become infected again. This means that people should not currently get tested to determine whether or not they are protected against COVID-19.
Additionally, antibody tests should not be routinely used to diagnose acute cases of COVID-19. Our bodies need time to make antibodies. It takes a week or 2 before detectible SARS-CoV-2 antibodies are produced. That means that during the acute stage of infection, antibody tests are likely to be negative and can be misleading.
However, there are select clinical situations when antibody testing might be used to facilitate a diagnosis. For example, if someone presents with symptoms late in a disease course, and tests negative for SARS-CoV-2 RNA, antibody testing could be considered.
What does EUA mean?
In the United States, tests for SARS-CoV-2 have what’s called an EUA. EUA stands for Emergency Use Authorization. Under section 564 of the Federal Food, Drug and Cosmetic or FD&C Act, in times of emergency (like the current COVID-19 pandemic), when there are no adequate, approved and available alternatives, the FDA Commissioner may allow the use of unapproved medical products or authorize unapproved uses of approved medical products to diagnose, treat or prevent serious or life-threatening diseases or conditions caused by chemical, biological, radiological or nuclear threats.
EUAs are based on the best available evidence at the time and remain in effect until the emergency ends, or new evidence causes the authorization to be withdrawn. EUAs are not the same as FDA clearance or approval.
There is currently no specific FDA approved treatment for COVID-19, with many candidate drugs being pushed through clinical trials.
A repurposed injected antiviral drug, remdesivir, has received EUA for COVID-19 treatment. Remdesivir targets the machinery SARS-CoV-2 uses to replicate itself inside of our cells.
EIDD-2801 is another antiviral drug being evaluated for SARS-CoV-2, but unlike remdesivir, is administered by mouth. It’s an investigational drug; clinical trials to evaluate its efficacy are ongoing.
Explanation:
please mark me as a brainlist